# Effect of maternal isolated hypothyroxinemia in the first trimester on offspring neurodevelopment: a prospective cohort study

**Authors:** Jing Du, Xiumei Xu, Ning Yuan, Xiaomei Zhang

PMC · DOI: 10.3389/fendo.2026.1734708 · Frontiers in Endocrinology · 2026-02-18

## TL;DR

Low thyroid hormone in mothers during early pregnancy is linked to poorer brain development and increased behavioral issues in their children.

## Contribution

This study is the first to prospectively link maternal isolated hypothyroxinemia in early pregnancy to offspring neurodevelopmental outcomes.

## Key findings

- Maternal isolated hypothyroxinemia in the first trimester is associated with lower developmental quotient in offspring.
- Offspring of mothers with IH show increased impulsive-hyperactive behaviors and social communication challenges.
- The strongest effect was observed in language development and hyperactivity indices.

## Abstract

This study aimed to examine the effect of maternal isolated hypothyroxinemia (IH) during early pregnancy on the neuropsychological development of the offspring.

This single-center prospective cohort study included 100 mother–child pairs, with 50 pairs in the IH group and an equal number in the euthyroid group. Levels of free thyroxine, thyroid-stimulating hormone, and thyroid peroxidase antibody in maternal serum were measured during the first trimester. Offspring neurodevelopment was evaluated using the Chinese Developmental Scale for Children Aged 0–6 Years (2nd Edition), Conners Parent Symptom Questionnaire, and Social Responsiveness Scale (SRS).

After adjusting for confounding factors, multiple linear regression analysis indicated that maternal IH in the first trimester was significantly associated with a decreased developmental quotient in the offspring (adjusted β = −3.28, 95% CI: −5.09 to −1.47, P < 0.001). The highest association was observed in the language domain (adjusted β = −5.72, 95% CI: −8.00 to −3.43, P < 0.001). Moreover, first-trimester IH exposure was linked to increased scores on the offspring’s impulsive–hyperactive behavior (adjusted β = 0.38, 95% CI: 0.16–0.60, P = 0.001) and hyperactivity index (adjusted β = 0.23, 95% CI: 0.06–0.41, P = 0.011). In addition, the offspring’s social awareness (adjusted β = 1.21, 95% CI: 0.10–2.31, P = 0.035) and social communication (adjusted β = 3.01, 95% CI: 0.50–5.53, P = 0.021) subscale scores as well as the total SRS score (adjusted β = 6.51, 95% CI: 0.33–12.69, P = 0.042) were elevated.

Maternal IH in the first trimester is associated with lower intellectual developmental scores and higher scores on screening scales for symptoms related to attention-deficit/hyperactivity disorder and autism spectrum disorder in the offspring.

## Linked entities

- **Diseases:** attention-deficit/hyperactivity disorder (MONDO:0007743), autism spectrum disorder (MONDO:0005258)

## Full-text entities

- **Genes:** SNAP25 (synaptosome associated protein 25) [NCBI Gene 6616] {aka CMS18, DEE117, RIC-4, RIC4, SEC9, SNAP}, GRIA1 (glutamate ionotropic receptor AMPA type subunit 1) [NCBI Gene 2890] {aka GLUH1, GLUR1, GLURA, GluA1, HBGR1, MRD67}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}
- **Diseases:** birth defects (MESH:D000014), Symptom (MESH:D012816), CDSC-II (MESH:C537730), TH deficiency (MESH:D007153), hypothyroidism (MESH:D007037), thyroid cancer (MESH:D013964), brain abnormalities (MESH:D001927), ADHD (MESH:D001289), abortion (MESH:D000026), neuropsychiatric (MESH:C000631768), delayed (MESH:D006968), encephalitis (MESH:D004660), neonatal hypoglycemia (MESH:D007003), hypertensive disorders of pregnancy (MESH:D046110), impulsive-hyperactive behavior (MESH:D011595), preterm birth (MESH:D047928), neonatal asphyxia (MESH:D001237), impulsive-hyperactive (MESH:D007174), fetal distress (MESH:D005316), miscarriage (MESH:D000022), stillbirth (MESH:D050497), thyroid disorder (MESH:D013959), type 1 diabetes mellitus (MESH:D003922), delays in cognitive and motor development (MESH:D002658), hypoxic-ischemic encephalopathy (MESH:D020925), conduct problems (MESH:D019973), cognitive impairment (MESH:D003072), inflammatory (MESH:D007249), ASD (MESH:D000067877), kernicterus (MESH:D007647), neurodevelopmental or psychiatric disorders (MESH:D001523), anxiety (MESH:D001007), schizophrenia (MESH:D012559), meningitis (MESH:D008580), autism (MESH:D001321), preeclampsia (MESH:D011225), gestational diabetes mellitus (MESH:D016640), hyperthyroidism (MESH:D006980), learning problems (MESH:D007859), hyperactivity (MESH:D006948), , hematological, or autoimmune diseases or tumors (MESH:D019337), psychosomatic disorders (MESH:D011602), IH (MESH:C565377)
- **Chemicals:** T4 (MESH:D013974), FT3 (-), amiodarone (MESH:D000638), iodine (MESH:D007455), T3 (MESH:D014284), alcohol (MESH:D000438), folate (MESH:D005492), lithium (MESH:D008094)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12957080/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12957080/full.md

## References

49 references — full list in the complete paper: https://tomesphere.com/paper/PMC12957080/full.md

---
Source: https://tomesphere.com/paper/PMC12957080